We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Article |  FREE
Raymond Pitetti, MD, MPH; Peter J. Davis, MD; Robert Redlinger, RN, MSN; et al.
Arch Pediatr Adolesc Med. 2006;160(2):211-216. doi:10.1001/archpedi.160.2.211.

Article |  FREE
Raymond D. Pitetti, MD, MPH; Sonia Singh, MD, MPH; Mary Clyde Pierce, MD
Arch Pediatr Adolesc Med. 2003;157(11):1090-1096. doi:10.1001/archpedi.157.11.1090.

Special Feature |  FREE
Arch Pediatr Adolesc Med. 2001;155(3):412. doi:10.1001/archpedi.155.3.411.

Special Feature |  FREE
Hal E. Palmer, MD; Paula North, MD, PhD; Richard W. Nicholas, MD; et al.
Arch Pediatr Adolesc Med. 1999;153(10):1107-1108. doi:10.1001/archpedi.153.10.1107.

Special Feature |  FREE
José A. Jiménez-Heffernan, MD; Pilar López-Ferrer, MD; Emilio Burgos, MD; et al.
Arch Pediatr Adolesc Med. 1998;152(5):509-510. doi:10.1001/archpedi.152.5.509.

Special Feature |  FREE
Wolfgang Pumberger, MD; Peter Wiesbauer, MD
Arch Pediatr Adolesc Med. 1998;152(2):201-202. doi:10.1001/archpedi.152.2.201.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
PD-L1 Expression as a Predictive Biomarker Is Absence of Proof the Same as Proof of Absence?
Feriyl Bhaijee, MD; Robert A. Anders, MD, PhD
JAMA Oncology
Viewpoint  | 
PD-L1 Testing in Cancer Challenges in Companion Diagnostic Development
Aaron R. Hansen, MBBS (Hons), FRACP; Lillian L. Siu, MD
JAMA Dermatology
Original Investigation  | 
The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma
Rui Xu, BS; Mu-Yan Cai, MD; Rong-Zhen Luo, MD; et al.
JAMA Oncology
Original Investigation  | 
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.